Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
作者信息
Revollo Boris, Tebe Cristian, Peñafiel Judith, Blanco Ignacio, Perez-Alvarez Nuria, Lopez Ruth, Rodriguez Laura, Ferrer Josep, Ricart Pilar, Moret Enrique, Tural Cristina, Carreres Anna, Matllo Joan, Videla Sebastià, Clotet Bonaventura, Llibre Josep M
机构信息
Division of Infectious Diseases and FLS Foundation for Fighting AIDS, Infectious Diseases and Promoting Health and Science, University Hospital Germans Trias, Badalona, Spain.
Biostatistics Unit, Bellvitge Biomedical Research Institute (IDIBELL)/University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.
出版信息
J Antimicrob Chemother. 2021 Feb 11;76(3):827-829. doi: 10.1093/jac/dkaa477.
Abstract
摘要
相似文献
1
Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.医护人员中使用羟氯喹进行COVID-19暴露前预防
J Antimicrob Chemother. 2021 Feb 11;76(3):827-829. doi: 10.1093/jac/dkaa477.
2
Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course.羟氯喹用于2019冠状病毒病暴露前预防：争论与未来建议方向
Expert Rev Anti Infect Ther. 2021 Apr;19(4):413-417. doi: 10.1080/14787210.2021.1828062. Epub 2020 Oct 7.
3
Hydroxychloroquine pre-exposure prophylaxis provides no protection against COVID-19 among health care workers: a cross-sectional study in a tertiary care hospital in North India.羟氯喹暴露前预防不能为医护人员提供针对 COVID-19 的保护：印度北部一家三级保健医院的横断面研究。
J Basic Clin Physiol Pharmacol. 2022 Jan 7;33(1):103-107. doi: 10.1515/jbcpp-2021-0221.
4
Sharing experience: Hydroxychloroquine in preexposure prophylaxis against COVID-19.经验分享：羟氯喹用于COVID-19暴露前预防
Indian J Pharmacol. 2021 Sep-Oct;53(5):420-421. doi: 10.4103/ijp.ijp_508_21.
5
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for Effectiveness.寻找羟氯喹预防 COVID-19 的剂量：对有效性的迫切探索。
Clin Pharmacol Ther. 2020 Oct;108(4):766-769. doi: 10.1002/cpt.1874. Epub 2020 Jun 1.
6
Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.COVID-19 大流行期间，高危医护人员用羟氯喹进行暴露前预防：一项多中心、双盲随机对照试验的研究方案的结构化总结。
Trials. 2020 Jul 29;21(1):688. doi: 10.1186/s13063-020-04621-7.
7
Why is pre-exposure prophylaxis with hydroxychloroquine a safe and rationale approach against SARS-CoV-2 infection?为什么用羟氯喹进行暴露前预防是一种安全且合理的针对 SARS-CoV-2 感染的方法？
J Glob Antimicrob Resist. 2020 Sep;22:864-865. doi: 10.1016/j.jgar.2020.07.022. Epub 2020 Aug 7.
8
Intravenous ozonized saline therapy as prophylaxis for healthcare workers (HCWs) in a dedicated COVID-19 hospital in India - A retrospective study.静脉注射臭氧生理盐水疗法作为印度一家专门的 COVID-19 医院医护人员（HCWs）的预防措施-一项回顾性研究。
Eur Rev Med Pharmacol Sci. 2021 May;25(9):3632-3639. doi: 10.26355/eurrev_202105_25847.
9
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada.羟氯喹暴露前预防以保护一线医护人员免受 COVID-19 感染：一项在加拿大多伦多进行的随机安慰剂对照多中心试验的研究方案的结构化总结。
Trials. 2020 Jul 14;21(1):647. doi: 10.1186/s13063-020-04577-8.
10
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.羟氯喹与安慰剂对医护人员暴露前预防新型冠状病毒的疗效和安全性：一项随机临床试验
JAMA Intern Med. 2021 Feb 1;181(2):195-202. doi: 10.1001/jamainternmed.2020.6319.
引用本文的文献
1
Hospital-Based Quasi-Experimental Study on Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Providers with Its Potential Side-Effects.关于医护人员使用羟氯喹进行新冠病毒病暴露前预防及其潜在副作用的基于医院的准实验研究
Life (Basel). 2022 Dec 7;12(12):2047. doi: 10.3390/life12122047.
2
Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.新型冠状病毒肺炎患者与非新型冠状病毒肺炎患者短期口服氯喹和羟氯喹治疗的安全性：一项系统评价
Pharmaceuticals (Basel). 2022 May 21;15(5):634. doi: 10.3390/ph15050634.
3
Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India.医护人员中使用羟氯喹进行COVID-19暴露前预防：来自印度的初步经验。
J Family Med Prim Care. 2022 Mar;11(3):1140-1145. doi: 10.4103/jfmpc.jfmpc_1177_21. Epub 2022 Mar 10.
4
HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.艾滋病毒和 COVID-19：从艾滋病毒和性传播感染减少伤害策略中吸取的教训。
Curr HIV/AIDS Rep. 2021 Aug;18(4):261-270. doi: 10.1007/s11904-021-00562-1. Epub 2021 Jun 8.
5
Prophylaxis for COVID-19: a systematic review.预防 COVID-19：系统评价。
Clin Microbiol Infect. 2021 Apr;27(4):532-537. doi: 10.1016/j.cmi.2021.01.013. Epub 2021 Jan 18.
6
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review.靶向SARS-CoV-2感染炎症反应的挑战与机遇：一篇综述
J Clin Med. 2020 Dec 12;9(12):4021. doi: 10.3390/jcm9124021.
本文引用的文献
1
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.西班牙巴塞罗那北部大都市区医护人员在第一波大流行后 SARS-CoV-2 IgG 特异性抗体的血清流行率。
PLoS One. 2020 Dec 28;15(12):e0244348. doi: 10.1371/journal.pone.0244348. eCollection 2020.
2
Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial.羟氯喹治疗轻症 2019 年冠状病毒病成人患者的随机对照临床试验。
Clin Infect Dis. 2021 Dec 6;73(11):e4073-e4081. doi: 10.1093/cid/ciaa1009.
3
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.西班牙 2020 年人群血清流行病学研究（ENE-COVID）：全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
4
Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.西班牙一家大型教学医院医护人员中 SARS-CoV-2 抗体的血清阳性率。
Nat Commun. 2020 Jul 8;11(1):3500. doi: 10.1038/s41467-020-17318-x.
5
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
6
Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020.2020 年 2 月 12 日-4 月 9 日美国 COVID-19 患者医护人员特征。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):477-481. doi: 10.15585/mmwr.mm6915e6.
7
Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?氯喹/羟氯喹在2019冠状病毒病（COVID-19）治疗中会有害吗？
Clin Infect Dis. 2020 Jul 28;71(15):888-889. doi: 10.1093/cid/ciaa321.
8
Reducing bias using propensity score matching.使用倾向得分匹配减少偏倚。
J Nucl Cardiol. 2018 Apr;25(2):404-406. doi: 10.1007/s12350-017-1012-y. Epub 2017 Aug 3.
Zotero 插件